Document Detail


Dilatation of the left ventricular cavity on dipyridamole thallium-201 imaging: a new marker of triple-vessel disease.
MedLine Citation:
PMID:  1990750     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To investigate the significance and mechanism of dilatation of the left ventricular cavity on dipyridamole thallium-201 imaging, we performed both dipyridamole thallium-201 imaging and dipyridamole radionuclide angiography on 83 patients with known angiograms. The dipyridamole/delayed ratio of the left ventricular dimension from the thallium-201 image was defined as the left ventricular dilatation ratio (LVDR). An LVDR greater than the mean + two standard deviations in patients without coronary artery disease was defined as abnormal. Twenty-two of 83 patients showed an abnormal LVDR, and 18 of the 22 patients (82%) had triple-vessel disease. By defect and washout analysis, the sensitivity and specificity for correctly identifying the patients as having triple-vessel disease was 72% and 76%, respectively, whereas LVDR had a sensitivity of 72% and a specificity of 93%. When LVDR was used in combination with the defect and washout criteria, sensitivity increased to 84% without a loss of specificity. In those 22 patients with abnormal LVDRs, end-diastolic volume measured by radionuclide angiography did not change after dipyridamole infusion. Dilatation of the left ventricular cavity on dipyridamole thallium-201 imaging reflected relative subendocardial hypoperfusion induced by dipyridamole rather than actual chamber enlargement. The LVDR was moderately sensitive and highly specific for triple-vessel disease and provided complementary information to dipyridamole thallium-201 imaging.
Authors:
Y Takeishi; I Tono-oka; K Ikeda; A Komatani; K Tsuiki; S Yasui
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  121     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1991 Feb 
Date Detail:
Created Date:  1991-03-06     Completed Date:  1991-03-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  466-75     Citation Subset:  AIM; IM    
Affiliation:
First Department of Internal Medicine, Yamagata University School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Coronary Disease / physiopathology,  radionuclide imaging*
Dipyridamole / diagnostic use*
Female
Gated Blood-Pool Imaging* / methods
Heart Catheterization
Hemodynamics / physiology
Humans
Male
Middle Aged
Thallium Radioisotopes / diagnostic use*
Vasodilation / drug effects*,  physiology
Ventricular Function, Left / drug effects*,  physiology
Chemical
Reg. No./Substance:
0/Thallium Radioisotopes; 58-32-2/Dipyridamole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors associated with recurrent myocardial infarction within one year after acute myocardial infar...
Next Document:  Percutaneous balloon valvotomy for patients with mitral stenosis: initial and follow-up results.